114results about How to "More effective" patented technology

Described is a prosthetic valve assembly comprising: a radially self-expandable stent configured to expand to bear against a wall of a native body lumen; and an implantable prosthetic valve, having a diameter, the valve being mounted inside the stent; wherein the diameter of the stent is greater than the diameter of the prosthetic valve.

This invention relates to novel fusion proteins which are comprised of a targeting protein that binds tissue factor (TF), which is operably linked to the thrombomodulin (TM) EGF456 domain alone or in combination with at least one other TM domain selected from the group consisting of the N-terminal hydrophobic region domain, the EGF123 domain, the interdomain loop between EGF3 and EGF4, and the O-glycosylated Ser / Thr-rich domain, or analogs, fragments, derivatives or variants thereof. The fusion protein binds at the site of injury and prevents the initiation of thrombosis. The fusion protein can be used to treat a variety of thrombotic conditions including but not limited to deep vein thrombosis, disseminated intravascular coagulation, and acute coronary syndrome.

This invention relates to novel fusion proteins which are comprised of a targeting protein that binds tissue factor (TF), which is operably linked to the thrombomodulin (TM) EGF456 domain alone or in combination with at least one other TM domain selected from the group consisting of the N-terminal hydrophobic region domain, the EGF123 domain, the interdomain loop between EGF3 and EGF4, and the O-glycosylated Ser / Thr-rich domain, or analogs, fragments, derivatives or variants thereof. The fusion protein binds at the site of injury and prevents the initiation of thrombosis. The fusion protein can be used to treat a variety of thrombotic conditions including but not limited to deep vein thrombosis, disseminated intravascular coagulation, and acute coronary syndrome.

A highly specific and easily purified form of hyaluronidase is described for use in ophthalmic treatments. The enzyme, from Streptomyces hyalurolyticus is specific for hyaluronidase and carries out an elimination reaction that results in the production of double bonds at the nonreducing end of hyaluronic acid. Hyaluronidase from Streptomyces hyalurolyticus has a higher activity than comparable enzymes from other species. The enzyme is now capable of being purified in what is essentially a protease-free form making it applicable to medical treatments. The use of this source of hyaluronidase in ophthalmic treatments is now made possible by its high activity, specificity for hyaluronidase and purity.

Novel molecules based upon hybridization of curcumin and hydroxystilbenes, such as resveratrol. It is believed that these novel molecules will have special application in treating Alzheimer's Disease.

A system and method for automatically constructing personalized video clips for a viewer.

A method and an apparatus for extracting signals which are indicative of the level of consciousness of a patient comprises subjecting the patient to a repetitive audio stimulus, monitoring AEP produced by the patient using an autoregressive model with exogenous input, and then calculating an index (AAI), which is displayed or used otherwise,indicative of the anaesthetic depth.

The invention provides a remote monitoring system which has a simplified configuration and is capable of remotely monitoring the current state of a person needing care and detecting an abnormality in the person's behavior and then addressing the abnormality, and further provides a method using the remote monitoring system. The remote monitoring system comprises: a communication line 3 for sending information indicating occurrence of an abnormality from a security device 1 to a terminal device 2 via an email support line and a telephone line; a central processing unit 11 for detecting that a user at said terminal device does not acquire the information indicating occurrence of an abnormality until a first predetermined time period has passed since the security device began sending the information indicating occurrence of an abnormality and sending out a first detection signal, and for detecting that the user at said terminal device does not acquire the information indicating occurrence of an abnormality until a second predetermined time period has passed since expiration of said first predetermined time period and sending out a second detection signal; detection means consisting of a detection circuit 16, etc.; control means consisting of the central processing unit 11 and a communication control unit 15, etc., and provided for allowing the communication line 3 to provide the email support line until the first predetermined time period has passed since the information indicating occurrence of an abnormality began to be sent and to provide the telephone line in response to the first detection signal; and an alarm generation unit 17, provided in the security device 1, for generating a first alarm in response to the first detection signal and generating a second alarm, which rings louder than the first alarm does, in response to the second detection signal.

The invention provides a remote monitoring system which has a simplified configuration and is capable of remotely monitoring the current state of a person needing care and detecting an abnormality in the person's behavior and then addressing the abnormality, and further provides a method using the remote monitoring system. The remote monitoring system comprises: a communication line 3 for sending information indicating occurrence of an abnormality from a security device 1 to a terminal device 2 via an email support line and a telephone line; a central processing unit 11 for detecting that a user at said terminal device does not acquire the information indicating occurrence of an abnormality until a first predetermined time period has passed since the security device began sending the information indicating occurrence of an abnormality and sending out a first detection signal, and for detecting that the user at said terminal device does not acquire the information indicating occurrence of an abnormality until a second predetermined time period has passed since expiration of said first predetermined time period and sending out a second detection signal; detection means consisting of a detection circuit 16, etc.; control means consisting of the central processing unit 11 and a communication control unit 15, etc., and provided for allowing the communication line 3 to provide the email support line until the first predetermined time period has passed since the information indicating occurrence of an abnormality began to be sent and to provide the telephone line in response to the first detection signal; and an alarm generation unit 17, provided in the security device 1, for generating a first alarm in response to the first detection signal and generating a second alarm, which rings louder than the first alarm does, in response to the second detection signal.